Evogene Ltd. Logo

Evogene Ltd.

AI-powered platform designing life-science solutions for health, ag, and industrial sectors.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Evogene Ltd. is a computational biology company that aims to revolutionize the discovery and development of life-science products. At its core is the proprietary Computational Predictive Biology (CPB) platform, which leverages big data and advanced artificial intelligence to design novel solutions based on microbes, small molecules, and genetic elements. The platform's tech-engines are designed to increase the probability of success while reducing development time and costs. Evogene's solutions cater to the human health, agriculture, and industrial sectors. The company operates through a group structure, licensing its technology to subsidiary companies that focus on specific commercial applications, thereby driving innovation across multiple life-science markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 16:15
Registration Form
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1
English 551.8 KB
2025-09-30 16:15
Foreign Filer Report
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1
English 36.4 KB
2025-09-30 16:00
Foreign Filer Report
Results of Operations- Six Months Ended June 30, 2025
English 372.7 KB
2025-09-30 16:00
Foreign Filer Report
Results of Operations- Six Months Ended June 30, 2025
English 36.5 KB
2025-09-10 16:00
Foreign Filer Report
Evogene Investor Presentation
English 1.8 MB
2025-09-10 16:00
Foreign Filer Report
Evogene Investor Presentation
English 36.5 KB
2025-08-28 16:00
Report Publication Announcement
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference …
English 110.4 KB
2025-08-28 16:00
Foreign Filer Report
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference …
English 36.6 KB
2025-08-19 16:00
Foreign Filer Report
Reports Second Quarter 2025 Financial Results
English 2.2 MB
2025-08-19 16:00
Foreign Filer Report
Reports Second Quarter 2025 Financial Results
English 36.7 KB
2025-08-19 01:00
Foreign Filer Report
Other Report or Announcement
English 122.5 KB
2025-08-12 16:00
Regulatory News Service
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 135.0 KB
2025-08-12 16:00
Foreign Filer Report
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 36.6 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 63.2 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 36.5 KB

Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Evogene Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland OCS
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154

Talk to a Data Expert

Have a question? We'll get back to you promptly.